Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biocryst Pharmaceuticals

8.44
+0.12001.44%
Post-market: 8.40-0.0400-0.47%19:47 EDT
Volume:4.97M
Turnover:42.30M
Market Cap:1.76B
PE:-19.63
High:8.62
Open:8.43
Low:8.39
Close:8.32
Loading ...

BioCryst Pharmaceuticals Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Yesterday

BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks
·
28 Apr

BioCryst to Report First Quarter 2025 Financial Results on May 5

GlobeNewswire
·
21 Apr

Bank of America Securities Keeps Their Buy Rating on BioCryst (BCRX)

TIPRANKS
·
17 Apr

BioCryst Pharmaceuticals Price Target Maintained With a $11.00/Share by RBC Capital

Dow Jones
·
11 Apr

How BioCryst Pharmaceuticals, Inc. (BCRX) Stock Stands Out in a Strong Industry

Zacks
·
11 Apr

BioCryst Pharmaceuticals CEO Takes On Finance Duties on Interim Basis

MT Newswires Live
·
11 Apr

BRIEF-Biocryst Pharmaceuticals Appoints Jon Stonehouse As Interim CFO & Interim Principal Accounting Officer - SEC Filing

Reuters
·
11 Apr

BioCryst CEO to serve as interim CFO

TIPRANKS
·
11 Apr

BioCryst Pharmaceuticals - on April 7, Jon P. Stonehouse Appointed Interim CFO & Interim Principal Accounting Officer - SEC Filing

THOMSON REUTERS
·
11 Apr

BioCryst Pharmaceuticals Price Target Maintained With a $15.00/Share by Needham

Dow Jones
·
10 Apr

RBC Capital Sticks to Their Buy Rating for BioCryst (BCRX)

TIPRANKS
·
05 Apr

BioCryst reports inducement grants under Nasdaq listing rule

TIPRANKS
·
04 Apr

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Apr

BioCryst to Present at Upcoming Investor Conference

GlobeNewswire
·
03 Apr

High Growth Tech Stocks In The US Market With Promising Potential

Simply Wall St.
·
28 Mar

Institutional investors control 75% of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and were rewarded last week after stock increased 4.9%

Simply Wall St.
·
19 Mar

The 4.9% return this week takes BioCryst Pharmaceuticals' (NASDAQ:BCRX) shareholders five-year gains to 295%

Simply Wall St.
·
18 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney

Reuters
·
12 Mar

BUZZ-BioCryst takes legal action to defend rare genetic drug patent; shares fall

Reuters
·
11 Mar